Sang-Don Park1, Chang-Hwan Yoon1, Il-Young Oh1, Jung-Won Suh1, Young-Suk Cho1, Tae-Jin Youn1, Dong-Ju Choi1, In-Ho Chae2. 1. Division of Cardiology, Department of Internal Medicine, Seoul National University Bundang Hospital, 82 Gumi-ro, 173 Bein-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, 463-707, Republic of Korea. 2. Division of Cardiology, Department of Internal Medicine, Seoul National University Bundang Hospital, 82 Gumi-ro, 173 Bein-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, 463-707, Republic of Korea. ihchae@snu.ac.kr.
Unfortunately, the original version of this article [1] contained an error. The correct paragraph can be found below:The calculation of number of patients was not correct. It was wrote the non-inferiority margin as 0.1 mm. But it was 0.19 mm in an original document. Non-inferiority margin in previous coronary intervention studies has been set between 0.1 ~ 0.2 mm. The 0.19 mm is not irrelevant in view of the current trial standard.